United States

Cochlear Ltd (COH.AX)

COH.AX on Australia Stock Exchange

27 Jun 2017
Change (% chg)

$-0.22 (-0.14%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for COH.AX


Cochlear Limited is engaged in providing implantable hearing solutions. The Company's implant systems comprise an implant, which is inserted during surgery and an external sound processor. The Company operates through three segments, based on geographical basis: Americas, EMEA and Asia Pacific. Americas includes the United... (more)


Beta: 0.67
Market Cap(Mil.): $9,110.16
Shares Outstanding(Mil.): 57.43
Dividend: 1.30
Yield (%): 1.58


  COH.AX Industry Sector
P/E (TTM): 44.13 34.12 19.11
EPS (TTM): 3.60 -- --
ROI: 32.81 13.11 -5.00
ROE: 45.68 15.62 -4.24

BRIEF-Cochlear announces acquisition of Sycle LLC

* Cochlear will acquire business of Sycle for a total consideration of an estimated US$78 million

May 10 2017

UPDATE 2-Australia's Cochlear books record half-year profit but China slump a worry

* Strong showing for U.S. sales help H1 profit surge 19 pct (Recasts, adds CEO and analyst comments)

Feb 13 2017

REFILE-Australia's Cochlear posts 19 pct profit rise

SYDNEY, Feb 14 Australia's Cochlear Ltd , the world No.1 hearing implants maker, on Tuesday posted a half-year profit rise of 19 percent, but reported slowing sales growth in Asia.

Feb 13 2017

BRIEF-Cochlear Ltd says HY total revenue A$609.2 mln

* Cochlear ltd says half-year profit attributable to members A$111.367 million versus A$94.0 million last year

Feb 13 2017

BRIEF-Cochlear appoints Brent Cubis as CFO

* Appoints Brent Cubis as chief financial officer Source text for Eikon: Further company coverage:

Feb 09 2017

More From Around the Web

Earnings vs. Estimates